Asieris’ progress in MIBC receives renewed attention with its inclusion in ASCO 2023

Asieris Pharmaceuticals announced the phase I clinical data of ANTICIPATE Study was published for the first time at the 2023 American Society of Clinical Oncology annual meeting in Chicago.